ReviewMagnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine2026
Integrating Artificial Intelligence into Prostate MR Imaging: Technical Foundations, Clinical Applications, and Workflow Implications.
Review in Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Two-Stage Allocation-Transportation Framework with Improved Holistic Swarm Optimization for Port Cargo Transportation Planning.Biomimetics (Basel, Switzerland) · 2026Article
- The Role of MRI in the Clinical Management of Urologic and Nephrological Disorders.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostate MRI has become a cornerstone of contemporary prostate cancer diagnosis, enabling improved detection of clinically significant disease while reducing unnecessary biopsies and overtreatment. However, prostate MRI remains technically demanding, time-consuming, and subject to inter-reader variability, particularly as healthcare systems move toward abbreviated protocols such as non-contrast MRI (biparametric MRI). In this context, artificial intelligence (AI) has emerged as a promising tool to enhance image quality, diagnostic consistency, and workflow efficiency across the prostate MRI pathway. This non-systematic narrative review provides a comprehensive overview of the technical foundations, clinical applications, and workflow implications of AI integration into prostate MRI. It summarizes key concepts in machine learning and deep learning relevant to prostate imaging and reviews current evidence supporting AI-based solutions for image quality assessment and reconstruction, automated prostate segmentation, lesion detection, and risk stratification. Particular attention is given to human-AI collaboration models, the role of AI in supporting equivocal lesions, and the integration of imaging with clinical variables for personalized risk estimation. In addition, it discusses the impact of AI on reporting efficiency, training, and standardization, as well as the current landscape of commercially available AI tools. Despite encouraging results from large multicenter studies, important challenges remain, including heterogeneity in study design, limited prospective validation, generalizability across institutions, and ethical and regulatory considerations. Overall, AI should be regarded as a complementary decision-support technology rather than a replacement for radiologists. Thoughtful implementation, robust validation, and appropriate user training are essential to ensure that AI meaningfully enhances the quality, efficiency, and reliability of prostate MRI-based care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.